Session 6 Chair: Barry Hardy
Douglas Connect GmbH, Switzerland
Dr. Barry Hardy is the Managing Director of Douglas Connect, Switzerland.
He has coordinated the OpenTox project in predictive toxicology and the ToxBank infrastructure development project. He currently leads the infrastructure development for the IMI EBiSC stem cell banking project and eNanoMapper supporting nanotechnology safety assessment.
He has led the development of research and best practice activities in drug design and toxicology through founding the eCheminfo Community of Practice, InnovationWell and Scientists Against Malaria project.
Currently he is developing Douglas Connect and its Collaboration Pools supporting new business area development and growth.
Dr. Hardy obtained his Ph.D. in 1990 from Syracuse University working in computational science. He was a National Research Fellow at the FDA Center for Biologics and Evaluation, a Hitchings-Elion Fellow at Oxford University and CEO of Virtual Environments International.
He was a pioneer in the early 1990s in the development of Web technology applied to virtual scientific communities and conferences. He has developed technology solutions for internet-based communications, tutor-supported e-learning, laboratory automation systems, and computational science and informatics.
In recent years he has been active in the field of knowledge management as applied to supporting innovation, communities of practice, and collaboration.